Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: Results from a multi-institutional consortium of prospective trials

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 5, 2013, Pages 939-945

  King, Christopher R ^a   Collins, Sean ^b   Fuller, Donald ^c   Wang, Pin Chieh ^a   Kupelian, Patrick ^a   Steinberg, Michael ^a   Katz, Alan ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Genesis Healthcare Partners   (United States)

^d Flushing Radiation Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; EXPANDED PROSTATE CANCER INDEX COMPOSITES; HEALTH-RELATED QUALITY OF LIVES; LOCALIZED PROSTATE CANCER; LONG-TERM OUTCOME; METHODS AND MATERIALS; PROSTATE CANCERS; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY; TOXICITY;

DISEASES;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; BLADDER; CLINICAL TRIAL; CONVALESCENCE; HEALTH STATUS; IMAGE GUIDED RADIOTHERAPY; ORGANS AT RISK; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; QUALITY CONTROL; RADIATION RESPONSE; RADIOSURGERY; RECTUM; SELF REPORT; SEXUALITY; TIME; TREATMENT OUTCOME;

AGED; BENCHMARKING; HEALTH STATUS; HUMANS; MALE; ORGANS AT RISK; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY, IMAGE-GUIDED; RECOVERY OF FUNCTION; RECTUM; SELF REPORT; SEXUALITY; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER;

EID: 84888298095     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.08.019     Document Type: Article

References (25)

1. E.E. Yeoh, R.J. Botten, and J. Butters Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial Int J Radiat Oncol Biol Phys 81 2011 1271 1278
2. G. Arcangeli, J. Fowler, and S. Gomellini Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 79 2011 1013 1021
3. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
4. J.E. Livsey, R.A. Cowan, and J.P. Wylie Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254 1259
5. M. Lock, L. Best, and E. Wong A phase ii trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1306 1315
6. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089
7. D. Dearnaley, I. Syndikus, and G. Sumo Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial Lancet Oncol 13 2012 43 54
8. J.H. Coote, J.P. Wylie, and R.A. Cowan Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity Int J Radiat Oncol Biol Phys 74 2009 1121 1127
9. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430
10. C.R. King, J.D. Brooks, and H. Gill Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer Int J Radiat Oncol Biol Phys 82 2012 877 882
11. D.B. Fuller, J. Naitoh, and C. Lee Virtual HDR CyberKnife treatment for localized prostatic carcinoma: Dosimetry comparison with HDR brachytherapy and preliminary clinical observations Int J Radiat Oncol Biol Phys 70 2008 1588 1597
12. A.J. Katz, M. Santoro, and R. Ashley Stereotactic body radiotherapy for organ-confined prostate cancer BMC Urol 10 2010 1
13. S.M. McBride, D.S. Wong, and J.J. Dombrowski Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial Cancer 118 2012 3681 3690
14. G. Bolzicco, M.S. Favretto, and E. Scremin Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results Technol Cancer Res Treat 9 2010 473 477
15. J.L. Friedland, D.E. Freeman, and M.E. Masterson-McGary Stereotactic body radiotherapy: An emerging treatment approach for localized prostate cancer Technol Cancer Res Treat 8 2009 387 392
16. T.P. Boike, Y. Lotan, and L.C. Cho Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer J Clin Oncol 29 2011 2020 2026
17. King CR, Freeman D, Kaplan I, et al. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective Phase II trials. Radiother Oncol, in press.
18. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
19. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
20. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate cancer survivors N Engl J Med 358 2008 1250 1261
21. Y. Pardo, F. Guedea, and F. Aguiló Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687 4696
22. A. Katz, M. Ferrer, and J.F. Suárez (Multicentric Spanish Group of Clinically Localized Prostate Cancer). Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer Radiat Oncol 7 2012 194
23. P.J. Hoskin, A.M. Rojas, and P.J. Ostler Quality of life after radical radiotherapy for prostate cancer: Longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy Clin Oncol 25 2013 321 327
24. E. Selvin, A.L. Burnett, and E.A. Platz Prevalence and risk factors for erectile dysfunction in the US Am J Med 120 2007 151 157
25. B.S. Hoppe, R.C. Nichols, and R.H. Henderson Erectile funtion, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger Cancer 118 2012 4619 4626